Viprostol (INNTooltip International Nonproprietary Name, USANTooltip United States Adopted Name, BANTooltip British Approved Name; developmental code name CL-115347) is a synthetic prostaglandin E2 (PGE2) analogue which was under development for the treatment of alopecia (hair loss) but was never marketed. It is administered topically and was found to increase scalp hair growth in people with alopecia, albeit with mixed evidence of effectiveness. The drug was under development by American Cyanamid. It reached phase 3 clinical trials for treatment of alopecia in the 1980s, but development was discontinued due to inadequate effectiveness. Viprostol is also a vasodilator and was originally developed for the treatment of hypertension in the mid-1970s before being repurposed for alopecia.
See also List of investigational hair loss drugs
References


